PL2344471T3 - Pochodna 7-piperydynoalkilo-3,4-dihydrochinolonu - Google Patents

Pochodna 7-piperydynoalkilo-3,4-dihydrochinolonu

Info

Publication number: PL2344471T3
Authority: PL; Poland
Prior art keywords: piperidinoalkyl; dihydroquinolone; derivative; dihydroquinolone derivative
Prior art date: 2008-10-02

Application number

PL09817928T

Other languages

English (en)

Inventor

Kosuke Kanuma

Naoki Miyakoshi

Madoka Kawamura

Tsuyoshi Shibata

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-02

Filing date

2009-09-30

Publication date

2013-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42073652&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2344471(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-09-30 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

2013-12-31 Publication of PL2344471T3 publication Critical patent/PL2344471T3/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

PL09817928T 2008-10-02 2009-09-30 Pochodna 7-piperydynoalkilo-3,4-dihydrochinolonu PL2344471T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2008257072		2008-10-02
PCT/JP2009/067441 WO2010038901A1 (en)	2008-10-02	2009-09-30	7-piperidinoalkyl-3,4-dihydroquinolone derivative
EP09817928.6A EP2344471B1 (en)	2008-10-02	2009-09-30	7-piperidinoalkyl-3,4-dihydroquinolone derivative

Publications (1)

Publication Number	Publication Date
PL2344471T3 true PL2344471T3 (pl)	2013-12-31

Family

ID=42073652

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09817928T PL2344471T3 (pl)	2008-10-02	2009-09-30	Pochodna 7-piperydynoalkilo-3,4-dihydrochinolonu

Country Status (28)

Country	Link
US (1)	US8461182B2 (pl)
EP (1)	EP2344471B1 (pl)
JP (1)	JP5541279B2 (pl)
KR (1)	KR20110067026A (pl)
CN (1)	CN102239159B (pl)
AR (1)	AR073727A1 (pl)
AU (1)	AU2009300607C1 (pl)
BR (1)	BRPI0925343A2 (pl)
CA (1)	CA2739513A1 (pl)
CL (1)	CL2011000734A1 (pl)
CO (1)	CO6321164A2 (pl)
CY (1)	CY1114165T1 (pl)
DK (1)	DK2344471T3 (pl)
ES (1)	ES2424393T3 (pl)
HR (1)	HRP20130728T1 (pl)
IL (1)	IL212070A (pl)
MX (1)	MX2011003500A (pl)
MY (1)	MY154337A (pl)
NZ (1)	NZ592008A (pl)
PE (1)	PE20110410A1 (pl)
PL (1)	PL2344471T3 (pl)
PT (1)	PT2344471E (pl)
RS (1)	RS52964B (pl)
RU (1)	RU2498981C2 (pl)
SI (1)	SI2344471T1 (pl)
UA (1)	UA105187C2 (pl)
WO (1)	WO2010038901A1 (pl)
ZA (1)	ZA201102315B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2011219467A (ja) *	2010-03-26	2011-11-04	Taisho Pharmaceutical Co Ltd	７−ピペリジノアルキル−３，４−ジヒドロキノロン誘導体を含有する医薬
AU2011326071A1 (en)	2010-11-08	2013-05-23	Lycera Corporation	N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of RORy activity and the treatment of diseases
CA2872014A1 (en)	2012-05-08	2013-11-14	Lycera Corporation	Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ror.gamma. and the treatment of disease
AU2013259737A1 (en)	2012-05-08	2014-10-02	Lycera Corporation	Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
WO2014142477A1 (en) *	2013-03-12	2014-09-18	Bio-Pharm Solutions Co., Ltd.	Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes
US9809561B2 (en)	2013-12-20	2017-11-07	Merck Sharp & Dohme Corp.	Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
WO2015095788A1 (en)	2013-12-20	2015-06-25	Merck Sharp & Dohme Corp.	2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE
US9783511B2 (en)	2013-12-20	2017-10-10	Lycera Corporation	Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease
MX2016010998A (es)	2014-02-27	2017-03-31	Lycera Corp	Terapia celular adoptiva que usa un agonista de receptor huérfano gamma relacionado con receptor de ácido retinoico y métodos terapéuticos relacionados.
WO2015171610A2 (en)	2014-05-05	2015-11-12	Lycera Corporation	Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
JP6523337B2 (ja)	2014-05-05	2019-05-29	リセラ・コーポレイションＬｙｃｅｒａＣｏｒｐｏｒａｔｉｏｎ	ＲＯＲγのアゴニストとしての使用及び疾患治療のためのベンゼンスルホンアミド及び関連化合物
CA2975997A1 (en)	2015-02-11	2016-08-18	Merck Sharp & Dohme Corp.	Substituted pyrazole compounds as rorgammat inhibitors and uses thereof
WO2016179343A1 (en)	2015-05-05	2016-11-10	Lycera Corporation	DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE
WO2016201225A1 (en)	2015-06-11	2016-12-15	Lycera Corporation	Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of rory and the treatment of disease
AU2016344111A1 (en)	2015-10-27	2018-05-10	Merck Sharp & Dohme Corp.	Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof
KR20180070697A (ko)	2015-10-27	2018-06-26	머크 샤프 앤드 돔 코포레이션	Ror감마t 저해제로서의 치환된 인다졸 화합물 및 이의 용도
AU2016344118A1 (en)	2015-10-27	2018-05-10	Merck Sharp & Dohme Corp.	Heteroaryl substituted benzoic acids as rorgammat inhibitors and uses thereof
TWI719138B (zh) *	2016-02-12	2021-02-21	日商安斯泰來製藥股份有限公司	四氫異喹啉衍生物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO4750663A1 (es) *	1995-09-15	1999-03-31	Sanofi Synthelabo	Derivados de quinolein-2 (1h)-ona, su preparacion y su aplicacion en terapeutica
EP1432693A2 (en) *	2001-10-01	2004-06-30	Taisho Pharmaceutical Co. Ltd.	Mch receptor antagonists
HUP0700124A2 (en) *	2001-10-25	2007-06-28	Takeda Chemical Industries Ltd	Quinoline compound
US20050197350A1 (en) *	2003-03-31	2005-09-08	Taisho Pharmaceutical Co., Ltd.	Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
CN100475793C (zh) *	2003-03-31	2009-04-08	大正制药株式会社	喹唑啉衍生物及其制备药物的用途
US20050209274A1 (en)	2004-02-26	2005-09-22	Lynch John K	Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
BRPI0509299A (pt) *	2004-03-30	2007-09-18	Taisho Pharmaceutical Co Ltd	composto ou um sal, hidrato, ou solvato farmaceuticamente aceitável do mesmo, composição farmacêutica, e, métodos para a profilaxia ou o tratamento de doença, para reduzir ingestão de alimento de um indivìduo, para induzir saciedade em um indivìduo, para controlar ou reduzir ganho de peso em um indivìduo, para modular um receptor de mch em um indivìduo e para produzir uma composição farmacêutica
JP2008514546A (ja) *	2004-09-30	2008-05-08	大正製薬株式会社	ピリジン誘導体及びその使用に関連する治療法
US20100081825A1 (en) *	2006-10-06	2010-04-01	Taisho Pharmaceutical Co Ltd	1-naphthyl alkylpiperidine derivative

2009
- 2009-09-30 ES ES09817928T patent/ES2424393T3/es active Active
- 2009-09-30 AU AU2009300607A patent/AU2009300607C1/en not_active Ceased
- 2009-09-30 SI SI200930738T patent/SI2344471T1/sl unknown
- 2009-09-30 MY MYPI2011001430A patent/MY154337A/en unknown
- 2009-09-30 UA UAA201105428A patent/UA105187C2/uk unknown
- 2009-09-30 PL PL09817928T patent/PL2344471T3/pl unknown
- 2009-09-30 RS RS20130370A patent/RS52964B/sr unknown
- 2009-09-30 WO PCT/JP2009/067441 patent/WO2010038901A1/en not_active Ceased
- 2009-09-30 BR BRPI0925343-2A patent/BRPI0925343A2/pt not_active IP Right Cessation
- 2009-09-30 EP EP09817928.6A patent/EP2344471B1/en active Active
- 2009-09-30 PT PT98179286T patent/PT2344471E/pt unknown
- 2009-09-30 JP JP2011513768A patent/JP5541279B2/ja not_active Expired - Fee Related
- 2009-09-30 MX MX2011003500A patent/MX2011003500A/es active IP Right Grant
- 2009-09-30 PE PE2011000810A patent/PE20110410A1/es not_active Application Discontinuation
- 2009-09-30 RU RU2011117161/04A patent/RU2498981C2/ru not_active IP Right Cessation
- 2009-09-30 KR KR1020117007343A patent/KR20110067026A/ko not_active Ceased
- 2009-09-30 CA CA2739513A patent/CA2739513A1/en not_active Abandoned
- 2009-09-30 CN CN200980149091.2A patent/CN102239159B/zh not_active Expired - Fee Related
- 2009-09-30 DK DK09817928.6T patent/DK2344471T3/da active
- 2009-09-30 NZ NZ592008A patent/NZ592008A/en not_active IP Right Cessation
- 2009-09-30 US US13/122,281 patent/US8461182B2/en not_active Expired - Fee Related
- 2009-09-30 HR HRP20130728AT patent/HRP20130728T1/hr unknown
- 2009-10-01 AR ARP090103798A patent/AR073727A1/es unknown
2011
- 2011-03-29 ZA ZA2011/02315A patent/ZA201102315B/en unknown
- 2011-03-30 CO CO11038711A patent/CO6321164A2/es active IP Right Grant
- 2011-03-31 IL IL212070A patent/IL212070A/en not_active IP Right Cessation
- 2011-04-01 CL CL2011000734A patent/CL2011000734A1/es unknown
2013
- 2013-07-25 CY CY20131100633T patent/CY1114165T1/el unknown

Also Published As

Publication number	Publication date
AU2009300607B2 (en)	2014-02-27
AU2009300607C1 (en)	2014-08-07
DK2344471T3 (da)	2013-10-07
MY154337A (en)	2015-05-29
CL2011000734A1 (es)	2011-09-23
JP2012504549A (ja)	2012-02-23
BRPI0925343A2 (pt)	2015-07-28
US8461182B2 (en)	2013-06-11
AU2009300607A1 (en)	2010-04-08
JP5541279B2 (ja)	2014-07-09
ZA201102315B (en)	2012-06-27
KR20110067026A (ko)	2011-06-20
CY1114165T1 (el)	2016-08-31
HRP20130728T1 (en)	2013-10-11
HK1159622A1 (en)	2012-08-03
RS52964B (sr)	2014-02-28
MX2011003500A (es)	2011-05-02
AR073727A1 (es)	2010-11-24
CO6321164A2 (es)	2011-09-20
ES2424393T3 (es)	2013-10-01
NZ592008A (en)	2011-12-22
CA2739513A1 (en)	2010-04-08
EP2344471A4 (en)	2012-05-30
EP2344471A1 (en)	2011-07-20
SI2344471T1 (sl)	2013-11-29
UA105187C2 (uk)	2014-04-25
RU2011117161A (ru)	2012-11-10
PE20110410A1 (es)	2011-07-02
EP2344471B1 (en)	2013-07-24
IL212070A0 (en)	2011-06-30
US20110178304A1 (en)	2011-07-21
WO2010038901A1 (en)	2010-04-08
RU2498981C2 (ru)	2013-11-20
PT2344471E (pt)	2013-08-01
IL212070A (en)	2014-07-31
CN102239159A (zh)	2011-11-09
CN102239159B (zh)	2014-06-25

Publication	Publication Date	Title
SI2384326T1 (sl)	2014-06-30	Pirolo(2,3-d)pirimidinske spojine
ZA201102315B (en)	2012-06-27	7-piperidinoalkyl-3,4-dihyfroquinolone derivative
IL206765A0 (en)	2010-12-30	4,5-dihydro-oxazol-2-yl-amine derivatives
IL210548A0 (en)	2011-03-31	Spiroaminodihydrothiazine derivatives
ZA201100799B (en)	2011-10-26	Imidazopyridin-2-one derivatives
SG10201506608RA (en)	2015-09-29	3-deazaneplanocin derivatives
PT2336132E (pt)	2014-04-02	Derivado de morfolinopurina
EP2269993A4 (en)	2011-04-20	2-aminoquinazoline DERIVATIVE
ZA201100876B (en)	2011-10-26	Pyrrolopyridinylpyrimidin-2-ylamine derivatives
ZA201005769B (en)	2011-10-26	Bicycloamine derivative
IL208623A0 (en)	2010-12-30	Cyclopentylacrylamide derivative
IL210869A0 (en)	2011-04-28	Imidazothiadiazoles derivatives
IL208336A0 (en)	2010-12-30	Pyrisazinone derivatives
ZA201100948B (en)	2012-04-25	Acylaminobenzamide derivatives
IL210164A0 (en)	2011-03-31	Thiazolylpiperidine derivatives
IL213424A0 (en)	2011-07-31	Quinazolinamide derivatives
ZA201008052B (en)	2012-04-25	2-phenyl-4-cyclopropyl-pyrimidine derivatives
ZA201006992B (en)	2011-06-29	Hydroxyquinoxalinecarboxamide derivative
SI2266990T1 (sl)	2013-01-31	Spojina 3-fenilpirazolo(5,1-b)tiazola
IL212683A0 (en)	2011-07-31	Biphenylacetamide derivative
ZA201005346B (en)	2011-11-30	3,8-diaminotetrahydroquinoline derivative
IL213051A0 (en)	2011-07-31	Difluorophenyldiacylhydrazide derivatives
GB0810164D0 (en)	2008-07-09	Wedge-dek, shower-floor gradient-former
PT2319840E (pt)	2016-02-10	Derivado de aminopropilideno
GB0808831D0 (en)	2008-06-18	.